Wednesday, September 26, 2012

3:00     Registration and Check-In

6:00     Reception

7:00     Dinner (Music provided by Ken Goodman & Gary Bell of The Vienne Theatre)

8:30     Networking in President’s Lodge

Thursday, September 27, 2012

7:00     Breakfast

8:00     Opening Remarks

8:30     Robert J. Griffin, Ph.D, Associate Professor of Radiation Oncology and Alexandru S. Biris, Ph.D, Director, UALR Center for Integrative Nanotechnology

9:15      “Therapeutic Efficacy of Arsenic and Platinum: Drug Synergy and Unexpected Inorganic Chemistry in Combination Chemotherapy for Triple Negative Breast Cancer” by  Thomas O’Halloran, Morrison Professor of Chemistry; Director of the Chemistry of Life Processes Institute; Associate Director for Basic Sciences Research Northwestern University

10:00    Break

10:15     “Novel Histone Marks and Protein Post-translational Modification Pathways Revealed by Proteomics Approaches” by  Yingming Zhao, Professor Ben May Department for Cancer Research University of Chicago

11:00   “Multifunctional Nanoconjugates for Therapy and Imaging” by  Gayle Woloschak, Professor, Departments of Radiation Oncology and Radiology; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois

11:45     Lunch  “Winthrop Rockefeller Institute” by Christy Carpenter, CEO Winthrop Rockefeller Institute

1:30      “Overview of CDER Experience with Nanotechnology-related Drugs” by  Nakissa Sadrieh, Associate Director for Research Policy and Implementation at US Department of Health and Human Services, Washington, D.C.

2:15     “Image-Guided Nanotheranostics: Promises and Challenges” by  Chun Li, Professor in the Department of Experimental Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center

3:00     Break

3:15      “Interdisciplinary Approaches to Evaluate the Toxic Potential of Engineered Gold Nanoparticles and Carbon Nanotubes” by Yongbin Zhang, Ph.D, Toxicologist, National Center for Toxicological Research, Jefferson, Arkansas

3:30     “From the Nanoscale to Behavior:  Emergence of Mental Function and Dysfunction” by Woodrow Shew, Ph.D, Assistant Professor, Department of Physics, University of Arkansas at Fayetteville, Fayetteville, Arkansas

3:45     “Using Nanotechnology to Design New Anti-Methamphetamine Immunotherapies” by  Eric Peterson, Ph.D, Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas

4:00     “Development of Methods for Determining Nanoparticle Penetration into Vaginal Mucosal Tissue” by Germarie Sanchez-Pomales, Ph.D, Research Chemist, National Center for Toxicological Research, Jefferson, Arkansas

4:15      “Inorganic Nanoparticles for Biomedical Applications” by Y. Andrew Wang, Ph.D, Research Professor of Electrical Engineering, University of Arkansas at Fayetteville; President and Principal Scientist of Ocean NanoTech, LLC, Springdale, Arkansas

4:30     “Self-Assembly of Multifunctional Nano-Composites for Nanotheranostics” by Jin Woo Kim, Ph.D,  Professor, Department of Biological & Agricultural Engineering, University of Arkansas at Fayetteville; Bio/Nano Technology Laboratory, Institute for Nanoscience & Engineering, University of Arkansas at Fayetteville, Fayetteville, Arkansas

4:45      “Multifunctional Magnetic Nanoparticles for Drug Delivery and RF Thermal Ablation of Cancer Cells” by Yang Xu, Ph.D, Research Assistant Professor, Center for Integrative Nanotechnology Sciences, University of Arkansas at Little Rock, Little Rock, Arkansas

5:00     Poster Presentations

7:00     Dinner

8:30      Networking in President’s Lodge

Friday, September 28, 2012

7:00     Breakfast

8:00     “Effects of Nanomaterials on Blood Brain Barrier” by  Syed Ali, Ph.D, Senior Biomedical Research Scientist; Head, Neurochemistry Laboratory Division of Neurotoxicology, HFT-132, National Center for Toxicological Research/FDA; Adjunct Professor – Depts. of Biochemistry and Molecular Biology; Neurology; and Pharmacology & Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR, and Dept. of Pharmacology, Duke University Medical Center, Durham, NC 

8:45      “The National Nanotechnology Initiative: A Strategic Vision for Responsible Development”  by  Sally Tinkle, Ph.D, Deputy Director of the National Nanotechnology Coordination Office, Arlington, Virginia

9:30     “Toxicological Properties and Mechanisms of Health Care Nanomaterials” by Yuliang Zhao, Ph.D,  Senior Affiliate Member at the Methodist Hospital Research Institute; Director of the CAS Key Lab for Biomedical Effects of Nanomaterials & Nanosafety Institute of High Energy Physics, Chinese Academy of Sciences National Center for Nanoscience and Technology, China; Founder and Director of the Research Center for Cancer Nanotechnology at Tianjin Cancer Hospital, Beijing, China

10:15   Break

10:30   “Differential Effects Induced by Silver Nanoparticles in the Cardiovascular and Respiratory Systems” by  Carmen Gonzalez, Ph.D, Head of Cellular Physiology Laboratory, Falcudad de Ciencias Quimicas, Universidad Autónoma de San Luis Potosi (UASLP), San Luis Potosi, Mexico

11:15     “New Opportunities for Nanotechnology and Materials Science in Regenerative Medicine” by  Kevin Shakesheff, Ph.D, Head of School of Pharmacy, Professor of Drug Delivery & Tissue Engineering Centre for Biomolecular Sciences, University of Nottingham, Nottingham, United Kingdom

12:00    Lunch

1:30     “Enabling Nanotechnology: Promise to Control Emerging and Re-emerging Infectious Diseases” by  Basavaraj Madhusudhan, Ph.D, Professor and Dean, Research Centre for Nano Science and Technology, Department of Bio-Chemistry and Food Technology, Davangere University, Shivagangothri, India

 2:15     “Multifunctional Nano Systems for Biomedical Applications” by Donglu Shi, Ph.D, Professor, Department of Chemical and Materials Engineering, University of Cincinnati, Cincinnati, Ohio

3:00     Break

3:15     Commercialization Discussion Panel (Moderators – Drs. Ajay P. Malshe and Ryan Tian)

• Dr. Mary L. Good, Founding Dean, University of Arkansas at Little Rock College of Engineering & Information Technology
• Vincent Caprio, Executive Director, NanoBusiness Commercialization Association
• Dr. Michael Douglas, Director, University of Arkansas for Medical Sciences BioVentures
• Michael Singleton, Innovation & Market Research Manager, Arkansas Small Business & Technology Development Center

5:00     Poster Presentations

7:00     Dinner (Commercialization presentation by Carol Reeves, Ph.D,  Associate Vice-Provost for Entrepreneurship at U of A – Fayetteville)

8:30      Networking in President’s Lodge

Saturday, September 29, 2012

8:00     Breakfast

9:15     “13-Week Toxicity Study of Nanoscale Silver” by Mary Boudreau, Research Toxicologist, National Center for Toxicological Research, Jefferson, Arkansas

9:45     Ajay Malshe, Ph.D, Director of  Materials, Manufacturing Processes, and Integrated Systems, Department of Mechanical Engineering, University of Arkansas; Founder/EVP/CTO of NanoMech, Fayetteville, Arkansas

10:15    Break

10:30   Statewide Nanotoxicity Efforts

• Dr. Mary L. Good, Founding Dean, University of Arkansas at Little Rock College of Engineering & Information Technology
• Dr. Paul Howard, Associate Director, Office of Scientific Coordination, National Center for Toxicological Research
• Dr. Thomas Flammang, Senior Advisor of Science, National Center for Toxicological Research

12:00   Lunch (Science as Art Winners Announced)

1:00     Conference Adjourned

Science as Art Competition

The Science as Art contest celebrates the creativity of the Arkansas research community with art from primary images generated by researchers. Submissions will be judged and winners will receive prizes. All art will be displayed at the 4th Annual Nanotechnology for Health Care Conference as well as the conference website, ArkansasNanoHealth.com.